Atossa Therapeutics logo
Atossa Therapeutics ATOS
$ 1.47 4.26%

Quarterly report 2024-Q2
added 08-12-2024

report update icon

Atossa Therapeutics Balance Sheet 2011-2024 | ATOS

Annual Balance Sheet Atossa Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -39.6 M -12.5 M -10.4 M -7.22 M -3.03 M -3.72 M -8.38 M -6.32 M -1.73 M -906 K

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

- - - 18.1 K 39.4 K - - - - - - - -

Total Non Current Liabilities

- - - - 11.1 K - - - - 51.7 K - - -

Total Current Liabilities

5.24 M 5.57 M 3.13 M 15.7 M 1.32 M 2.92 M 1.23 M 1.05 M 2.5 M 2.21 M 1.41 M 1.65 M -

Total Liabilities

5.24 M 5.57 M 3.13 M 15.7 M 1.33 M 2.92 M 1.23 M 1.05 M 2.5 M 2.27 M 1.41 M 1.65 M 1.51 M

Deferred Revenue

- - - - - - - - - - 48.2 K - -

Retained Earnings

-186 M -156 M -129 M - -94.1 M -76.8 M -65.4 M -57.3 M -50.9 M -35.2 M -20.5 M -9.73 M -4.65 M

Total Assets

96.3 M 124 M 141 M 42.8 M 14.5 M 11.7 M 8.16 M 4.14 M 6.24 M 11.8 M 12 M 6.83 M 3.07 M

Cash and Cash Equivalents

88.5 M 111 M 136 M 39.6 M 12.6 M 10.4 M 7.22 M 3.03 M 3.72 M 8.5 M 6.34 M 1.73 M 1.91 M

Book Value

91 M 118 M 138 M 27.2 M 13.2 M 8.81 M 6.94 M 3.1 M 3.74 M 9.5 M 10.6 M 5.18 M 1.56 M

Total Shareholders Equity

91 M 118 M 138 M 27.2 M 13.2 M 8.81 M 6.94 M 3.1 M 3.74 M 9.5 M 10.6 M 5.18 M 1.56 M

All numbers in USD currency

Quarterly Balance Sheet Atossa Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - 1.22 K 4.72 K 8.01 K 11.1 K 11.1 K 11.1 K 11.1 K - - - - - - - - - - - - - - 12.5 K 25.2 K 49.2 K - 49.2 K 49.2 K 5.82 K - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

5.7 M 5.33 M 5.24 M 3.44 M 3.48 M 2.94 M 5.57 M 2.87 M 3.79 M 2.32 M 3.13 M 1.68 M - - 15.7 M 15.7 M 1.83 M 916 K 1.33 M 1.33 M 1.33 M 1.33 M 2.92 M 2.92 M 2.92 M 2.92 M - - - - 1.05 M - - - 2.5 M 3.3 M 3.44 M 3.52 M 2.27 M 2.27 M 2.27 M 2.27 M 1.41 M - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-198 M -192 M -186 M -179 M -172 M -162 M -156 M -149 M -141 M -134 M -129 M -124 M -119 M -112 M -112 M -112 M -112 M -112 M -94.1 M -94.1 M -94.1 M -94.1 M -76.8 M -76.8 M -76.8 M -76.8 M -65.4 M -65.4 M -65.4 M -65.4 M -57.3 M -57.3 M -57.3 M -57.3 M -50.9 M -50.9 M -50.9 M -50.9 M -35.2 M -35.2 M -35.2 M -35.2 M -20.5 M -20.5 M -20.5 M -20.5 M -9.73 M -9.73 M -9.73 M -9.73 M -4.65 M -4.65 M - -

Total Assets

85.9 M 91.1 M 96.3 M 102 M 108 M 116 M 124 M 127 M 134 M 137 M 141 M 143 M 146 M 141 M 42.8 M 42.8 M 42.8 M 42.8 M 14.5 M 14.5 M 14.5 M 14.5 M 11.7 M 11.7 M 11.7 M 11.7 M 8.16 M 8.16 M 8.16 M 8.16 M 4.14 M 4.14 M 4.14 M 4.14 M 6.24 M 6.24 M 6.24 M 6.24 M 11.8 M 11.8 M 11.8 M 11.8 M 12 M 12 M 12 M 12 M 6.83 M 6.83 M 6.83 M 6.83 M 3.07 M 3.07 M - -

Cash and Cash Equivalents

79.5 M 84 M 88.5 M 94 M 99.4 M 104 M 111 M 117 M 126 M 131 M 136 M 140 M 142 M 138 M 39.6 M 39.6 M 39.6 M 39.6 M 12.6 M 12.6 M 12.6 M 12.6 M 10.4 M 10.4 M 10.4 M 10.4 M 7.22 M 7.22 M 7.22 M 7.22 M 3.03 M 3.03 M 3.03 M 3.03 M 3.72 M 3.72 M 3.72 M 3.72 M 8.5 M 8.5 M 8.5 M 8.5 M 6.34 M 6.34 M 6.34 M 6.34 M 1.73 M 1.73 M 1.73 M 1.73 M 1.91 M 1.91 M - -

Book Value

80.2 M 85.8 M 91 M 98.3 M 105 M 113 M 118 M 124 M 130 M 135 M 138 M 141 M 146 M 141 M 27.2 M 27.2 M 41 M 41.9 M 13.2 M 13.2 M 13.2 M 13.2 M 8.81 M 8.81 M 8.81 M 8.81 M 8.16 M 8.16 M 8.16 M 8.16 M 3.1 M 4.14 M 4.14 M 4.14 M 3.74 M 2.95 M 2.81 M 2.72 M 9.5 M 9.5 M 9.5 M 9.5 M 10.6 M 12 M 12 M 12 M 6.83 M 6.83 M 6.83 M 6.83 M 3.07 M 3.07 M - -

Total Shareholders Equity

80.2 M 85.8 M 91 M 98.3 M 105 M 113 M 118 M 124 M 130 M 135 M 138 M 141 M 144 M 140 M 27.2 M 27.2 M 27.2 M 27.2 M 13.2 M 13.2 M 13.2 M 13.2 M 8.81 M 8.81 M 8.81 M 8.81 M 6.94 M 6.94 M 6.94 M 6.94 M 3.1 M 3.1 M 3.1 M 3.1 M 3.74 M 3.74 M 3.74 M 3.74 M 9.5 M 9.5 M 9.5 M 9.5 M 10.6 M 10.6 M 10.6 M 10.6 M 5.18 M 5.18 M 5.18 M 5.18 M 1.56 M 1.56 M - -

All numbers in USD currency